您当前的位置：
首页 >
文章列表页 >
Mechanism of Guizhi Fulingwan on Oxidative Stress Factors and Renal Fibrosis in Diabetic Mice Based on Nrf2/ARE Signaling Pathway
更新时间：2024-08-21

    • Mechanism of Guizhi Fulingwan on Oxidative Stress Factors and Renal Fibrosis in Diabetic Mice Based on Nrf2/ARE Signaling Pathway

    • “The latest research found that Guizhi Fuling Pill can effectively improve oxidative stress and renal fibrosis in diabetes mice by activating Nrf2/ARE signaling pathway, providing a new strategy for the treatment of diabetes nephropathy.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 18, Pages: 43-51(2024)

    • DOI：10.13422/j.cnki.syfjx.20241002    

      CLC： R2-0;R22;R285.5;R289;R33

    • Received：08 March 2024，

      Published Online：17 July 2024，

      Published：20 September 2024

    移动端阅览

  • JIANG Xiyu,LIN Shaomin,FANG Guangqing,et al.Mechanism of Guizhi Fulingwan on Oxidative Stress Factors and Renal Fibrosis in Diabetic Mice Based on Nrf2/ARE Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(18):43-51. DOI： 10.13422/j.cnki.syfjx.20241002.

  •  
  •  

0

Views

86

下载量

1

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Traditional Chinese Medicine in Treatment of Diabetic Kidney Disease Based on Wnt/β-catenin Signaling Pathway： A Review
Herbal Cake-separated Moxibustion Improves Cognitive Function in Rat Model of Chronic Fatigue Syndrome via PI3K/Beclin1 Signaling Pathway
Zhenzhu Tiaozhi Capsules Reduce Renal Lipid Deposition and Inflammation in Mouse Model of Diabetic Kidney Disease via SCAP-SREBP-1c/NLRP3 Signaling Pathway
Effect of Shenkang Injection on Podocyte Apoptosis and GRP78/CHOP Signaling Pathway in db/db Mice with Diabetic Kidney Disease Based on Endoplasmic Reticulum Stress
Shenqi Dihuang Decoction Improves Renal Function in Mouse Model of Diabetic Kidney Disease by Inhibiting Arachidonic Acid-related Ferroptosis Via ACSL4/LPCAT3/ALOX15 Axis

Related Author

LI Ping
ZOU Manshu
WANG Yuhong
ZHAI Chuntao
HOU Yawei
SHI Linjuan
WANG Yixiao
TIAN Yuefeng

Related Institution

Technology Innovation Center，Hunan University of Chinese Medicine
Second Clinical College of Shanxi University of Chinese Medicine
Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine， Guangdong Pharmaceutical University
School of Traditional Chinese Medicine， Beijing University of Chinese Medicine
Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences
0